Repurposing Quaternary Ammonium Compounds as Potential Treatments for COVID-19.

Nancy BakerAntony J WilliamsAlexander TropshaSean Ekins

Published in: Pharmaceutical research (2020)

The COVID-19 pandemic has highlighted an important role for drug repurposing. Quaternary ammonium compounds such as ammonium chloride, cetylpyridinium and miramistin represent widely accessible antiseptic molecules with well-known broad-spectrum antiviral activities and represent a repurposing opportunity as therapeutics against SARS-CoV-2.

Keyphrases

sars cov
ionic liquid
respiratory syndrome coronavirus
coronavirus disease
small molecule
emergency department
risk assessment
human health
adverse drug
drug induced
electronic health record